Wellgistics Health discloses two director resignations

Wellgistics Health, Inc. reported that two members of its board of directors resigned effective February 1, 2026.

Rhea-AI Filing Summary

Wellgistics Health, Inc. reported that two members of its board of directors resigned effective February 1, 2026. Steven Lee resigned from the board and his role on the Ethics Committee, and Howard Doss resigned from the board and his role as chairman of the Audit Committee.

Both directors stated that their decisions to step down were not the result of any disagreement with the company regarding its operations, policies, or practices. The company also filed their formal resignation letters as exhibits to this report.

Insights

Corporate governance analyst

Two director resignations, including the audit chair, with no stated disagreements.

Wellgistics Health, Inc. disclosed that Steven Lee and Howard Doss resigned from the board on February 1, 2026. Lee also left the Ethics Committee, while Doss stepped down as chairman of the Audit Committee, which oversees financial reporting and controls.

The company states both resignations were not due to disagreements over operations, policies, or practices, which limits immediate concern about internal conflicts. However, losing an audit committee chair typically requires appointing qualified replacements to maintain strong oversight and exchange compliance.

Future disclosures in company filings may outline how the board is reconstituted, including new committee assignments and any added directors. These steps will clarify how governance and audit oversight are maintained following the departures on February 1, 2026.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

What did Wellgistics Health, Inc. (WGRX) announce in this 8-K filing?

Wellgistics Health, Inc. announced that two members of its board of directors resigned effective February 1, 2026. The filing explains their committee roles, states there were no disagreements with the company, and includes their formal resignation letters as exhibits for investors to review.

Which directors resigned from Wellgistics Health, Inc. (WGRX)?

Steven Lee and Howard Doss resigned from the Wellgistics Health, Inc. board of directors effective February 1, 2026. Lee had served on the Ethics Committee, while Doss was chairman of the Audit Committee, which plays a central role in financial reporting oversight.

Did the resigning WGRX directors report any disagreements with the company?

Both Steven Lee and Howard Doss indicated that their resignations were not the result of any disagreement with Wellgistics Health, Inc. The filing specifically notes there were no issues regarding the company’s operations, policies, or practices that led to their decisions to step down.

What board committee roles were affected by the WGRX director resignations?

Steven Lee resigned from the board and left the Ethics Committee, while Howard Doss resigned from the board and his position as chairman of the Audit Committee. The Audit Committee chair role is important for overseeing financial statements, internal controls, and related governance responsibilities.

Are the WGRX director resignation letters available to investors?

Yes. Wellgistics Health, Inc. attached each director’s resignation letter as an exhibit to the filing. Exhibit 17.1 contains Steven Lee’s resignation letter and Exhibit 17.2 contains Howard Doss’s resignation letter, both dated February 1, 2026, providing additional formal documentation of their decisions.

When did the Wellgistics Health, Inc. (WGRX) board resignations become effective?

The resignations of Steven Lee and Howard Doss became effective immediately on February 1, 2026. The 8-K notes that each director advised the company of his decision on that date, and the changes took effect right away, impacting the board and its committee composition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/05/2026 - 05:21 PM Learn about SEC filing dates

false 0002030763 0002030763 2026-02-01 2026-02-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 1, 2026

WELLGISTICS HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-42530		93-3264234
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3000 Bayport Drive

Suite 950

Tampa, FL 33607

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (844) 203-6092

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		WGRX		The Nasdaq Capital Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Director Resignations

On February 1, 2026, Steven Lee advised the Company that he was resigning from his position as a member of the board of directors effective immediately. Mr. Lee indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. At the time of his resignation, Mr. Lee served on the Ethics Committee.

On February 1, 2026, Howard Doss advised the Company that he was resigning from his position as a member of the board of directors effective immediately. Mr. Doss indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. At the time of his resignation, Mr. Doss served as chairman on the Audit Committee.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this Report.

Exhibit No.		Description
17.1		Director Resignation Letter of Steven Lee dated as of February 1, 2026
17.2		Director Resignation Letter of Howard Doss dated as of February 1, 2026
104*		Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 5, 2026	WELLGISTICS HEALTH, INC.
	By:	/s/ Prashant Patel
		Prashant Patel, President